BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34888386)

  • 1. Prognostic Role of TIGIT Expression in Patients with Solid Tumors: A Meta-Analysis.
    Xiao K; Xiao K; Li K; Xue P; Zhu S
    J Immunol Res; 2021; 2021():5440572. PubMed ID: 34888386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis.
    Li S; Li L; Pan T; Li X; Tong Y; Jin Y
    Front Immunol; 2022; 13():977016. PubMed ID: 36211383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
    Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
    [No Abstract]   [Full Text] [Related]  

  • 4. A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers.
    Hosseinkhani N; Shadbad MA; Asghari Jafarabadi M; Karim Ahangar N; Asadzadeh Z; Mohammadi SM; Lotfinejad P; Alizadeh N; Brunetti O; Fasano R; Silvestris N; Baradaran B
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallothioneins may be a potential prognostic biomarker for tumors: A Prisma-compliant meta-analysis.
    Wang L; Xin F; Lin N; Wang Y; Liu X; Liu J
    Medicine (Baltimore); 2018 Dec; 97(52):e13786. PubMed ID: 30593161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.
    Zhao X; Lu H; Sun Y; Liu L; Wang H
    Medicine (Baltimore); 2020 Oct; 99(42):e22804. PubMed ID: 33080755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
    Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
    Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
    Xia Y; Wei X; Gong H; Ni Y
    BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of immune checkpoint proteins in HPV-infected cervical cancer.
    Zou W; Huang R; Li P; Liu X; Huang Q; Yue J; Liu C
    J Infect Public Health; 2023 Apr; 16(4):542-550. PubMed ID: 36801634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis.
    Chen X; Liang R; Lai L; Chen K; Zhu X
    Front Oncol; 2021; 11():697369. PubMed ID: 34490092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis-associated protein 1 as a new prognostic marker for solid tumors: a meta-analysis of cohort studies.
    Luo H; Li H; Yao N; Hu L; He T
    Tumour Biol; 2014 Jun; 35(6):5823-32. PubMed ID: 24599674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Golgi phosphoprotein3 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.
    Jiang Y; Su Y; Zhao Y; Pan C; Chen L
    Int J Clin Exp Pathol; 2015; 8(9):10615-24. PubMed ID: 26617771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis.
    Sun Z; Xu R; Li X; Ren W; Ou C; Wang Q; Zhang H; Zhang X; Ma J; Wang H; Li G
    PLoS One; 2015; 10(8):e0135119. PubMed ID: 26263504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
    Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
    PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis.
    Zhang S; Liu W; Hu B; Wang P; Lv X; Chen S; Shao Z
    Front Immunol; 2020; 11():1242. PubMed ID: 32714321
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic Role of High Stathmin 1 Expression in Patients with Solid Tumors: Evidence from a Meta-Analysis.
    Mao Q; Chen Z; Wang K; Xu R; Lu H; He X
    Cell Physiol Biochem; 2018; 50(1):66-78. PubMed ID: 30278466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysis.
    Wang H; Zhang Q; Kong H; Zeng Y; Hao M; Yu T; Peng J; Xu Z; Chen J; Shi H
    Int J Clin Exp Pathol; 2014; 7(7):3876-86. PubMed ID: 25120764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma.
    Wang P; Chen Y; Long Q; Li Q; Tian J; Liu T; Wu Y; Ding Z
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34625514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies.
    Xu L; Zhang Y; Tang J; Wang P; Li L; Yan X; Zheng X; Ren S; Zhang M; Xu M
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):867-881. PubMed ID: 30602498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.